View Author
imatinib transporter cancer cisplatin patient study carnitine transport uptake expression pharmacokinetic clearance variant docetaxel wild-type mice nephrotoxicity pharmacol oct 1 substrate effect octn 2 genotype cyp 3a research response activity oct 2 association control abcb 1 tumor level treatment cisplatin nephrotoxicity concentration carrier analysis allele cation wild-type midazolam ermbt solute carriers slc 22a transfected protein oatp 1a erythromycin breath test haplotype erythromycin myeloid leukemia kidney result interaction function cancer research figure leukemia inhibitor american administration xenopus laevis oocytes number inhibition article cml patients cisplatin-induced plasma sample oocyte polymorphism probe midazolam clearance nag activity intracellular uptake cimetidine cyp 3a allele resistance value downloaded
7 Most Recent Publications
|
Environmental and Genetic Factors Affecting Transport of Imatinib by OATP1A2
(Article)
Eechoute, K. Franke, R.M. Sparreboom, A. Loos, W.J. Scherkenbach, L.A. Boer, I.H. de Verweij, J. Gurney, H. Kim, R.B. Tirona, R.G. Mathijssen, R.H.J. |
2011-04-20
|
|
Drug transporters and imatinib treatment: Implications for clinical practice
(Article)
Eechoute, K. Sparreboom, A. Burger, H. Franke, R.M. Schiavon, G. Verweij, J. Loos, W.J. Wiemer, E.A.C. Mathijssen, R.H.J. |
2011-02-01
|
|
Cisplatin-induced downregulation of OCTN2 affects carnitine wasting
(Article)
Lancaster, C.S. Hu, C. Franke, R.M. Filipski, K.K. Orwick, S.J. Chen, Z. Zuo, Z. Loos, W.J. Sparreboom, A. |
2010-10-01
|
|
Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-β-D-glucosaminidase
(Article)
Franke, R.M. Koloske, A.M. Lancaster, C.S. Filipski, K.K. Hu, C. Zolk, O. Matthijsen, R.H.J. Sparreboom, A. |
2010-08-15
|
|
Pharmacogenetic pathway analysis of docetaxel elimination
(Article)
Baker, S.D. Verweij, J. Messersmith, W.A. Wolff, A.C. Carducci, M.A. Sparreboom, A. Cusatis, G.A. Schaik, R.H.N. van Marsh, S. Orwick, S.J. Franke, R.M. Hu, S. Schuetz, E.G. Lamba, V. |
2009-02-01
|
|
Influence of solute carriers on the pharmacokinetics of CYP3A4 probes
(Article)
Franke, R.M. Baker, S.D. Mathijssen, R.H.J. Schuetz, E.G. Sparreboom, A. |
2008-12-01
|
|
Interaction of imatinib with human organic ion carriers
(Article)
Hu, S. Franke, R.M. Filipski, K.K. Orwick, S.J. Bruijn, E.A. de Baker, S.D. Burger, H. Sparreboom, A. |
2008-05-15
|